Nvwa Life Technology Co., Ltd.
Guangzhou Nvwa Life Technology Co., Ltd. is a world-leading innovative company focused on genome epigenetics research and medical transformation. Leveraging two core technology platforms – whole-genome library preparation for trace cells and a human epigenetics database – Nvwa Life develops and promotes products in the epigenetic field. Their product pathway spans assisted reproductive tests, obstetrical and neonatal epigenetic disease tests, and extends to epigenetic diagnosis and treatment. They are pioneers in Pre-Implantation Methylation Screening (PIMS), a technology that aims to increase live birth rates and reduce birth defects in Assisted Reproductive Technology (ART). Their PIMS technology is based on epigenetic technology combined with big data and AI algorithms, offering integrated solutions for reproduction. The company has received recognition, including the SRBT Award at ASRM 2024 and third prize in the HICOOL 2024 Global Entrepreneurship Competition. They have also established strategic cooperation agreements with major hospitals in China.
Nvwa Life Technology Co., Ltd.
Guangzhou Nvwa Life Technology Co., Ltd. is a world-leading innovative company focused on genome epigenetics research and medical transformation. Leveraging two core technology platforms – whole-genome library preparation for trace cells and a human epigenetics database – Nvwa Life develops and promotes products in the epigenetic field. Their product pathway spans assisted reproductive tests, obstetrical and neonatal epigenetic disease tests, and extends to epigenetic diagnosis and treatment. They are pioneers in Pre-Implantation Methylation Screening (PIMS), a technology that aims to increase live birth rates and reduce birth defects in Assisted Reproductive Technology (ART). Their PIMS technology is based on epigenetic technology combined with big data and AI algorithms, offering integrated solutions for reproduction. The company has received recognition, including the SRBT Award at ASRM 2024 and third prize in the HICOOL 2024 Global Entrepreneurship Competition. They have also established strategic cooperation agreements with major hospitals in China.